Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

AYTU holding history

Aytu Biopharma, Inc in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AYTU overviewAll 13F holders of AYTUFull Q2 2026 holdings

Shares (Q2 2026)
125
Value
$269
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AYTU by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026125$269<0.1%00.0%UnchangedHolders
Q1 2026125$341<0.1%00.0%UnchangedHolders
Q4 2025125$325<0.1%−161−56.3%ReducedHolders
Q3 2025286$538<0.1%00.0%UnchangedHolders
Q2 2025286$624<0.1%−4−1.4%ReducedHolders
Q1 2025290$348<0.1%00.0%UnchangedHolders
Q4 2024290$493<0.1%00.0%UnchangedHolders
Q3 2024290$681<0.1%−150−34.1%ReducedHolders
Q2 2024440$1.28K<0.1%−620−58.5%ReducedHolders
Q1 20241,060$3.22K<0.1%−340−24.3%ReducedHolders
Q4 20231,400$3.98K<0.1%00.0%UnchangedHolders
Q3 20231,400$3.78K<0.1%+960+218.2%AddedHolders
Q2 2023440$704<0.1%−584−57.0%ReducedHolders
Q1 20231,024$2.29K<0.1%00.0%UnchangedConverted for a 1-for-20 splitHolders
Q4 202220,491$3.87K<0.1%+60.0%AddedHolders
Q3 202220,485$4.00K<0.1%−5,001−19.6%ReducedHolders
Q2 202225,486$17.0K<0.1%−25,732−50.2%ReducedHolders
Q1 202251,218$56.0K<0.1%−138,924−73.1%ReducedHolders
Q4 2021190,142$257.0K<0.1%−187,780−49.7%ReducedHolders
Q3 2021377,922$1.09M<0.1%+335,625+793.5%AddedHolders
Q2 202142,297$212.0K<0.1%+40,919+2,969.4%AddedHolders
Q1 20211,378$10.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.